AVR
Following AVR, females had a greater odds of 30-day mortality compared to males (OR 1.59, CI 1.27-1.99, p<0.001) (see table 6). Female sex was protective against returning to theatre for post-operative bleeding (OR 0.72, CI 0.61-0.84, p<0.001) and deep sternal wound infections l SSI (OR 0.60, CI 0.33-1.03, p=0.074). There were no significant gender-related differences in outcomes of post-operative CVA (OR 1.03, CI 0.78-1.36, p=0.8), post-operative dialysis (OR 0.94, CI 0.76-1.15, p=0.5) and in hospital length of stay (beta 0.2, CI -0.20-0.60, p=0.3).
Table 6: Multivariable regression analysis of outcomes following AVR, females compared to males